Halazonetis TD - Search Results

1

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. Gorgoulis VG, et al. Among authors: halazonetis td. Nature. 2005 Apr 14;434(7035):907-13. doi: 10.1038/nature03485. Nature. 2005. PMID: 15829965

2

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

Gorgoulis VG, Zacharatos PV, Manolis E, Ikonomopoulos JA, Damalas A, Lamprinopoulos C, Rassidakis GZ, Zoumpourlis V, Kotsinas A, Rassidakis AN, Halazonetis TD, Kittas C. Gorgoulis VG, et al. Among authors: halazonetis td. Br J Cancer. 1998;77(3):374-84. doi: 10.1038/bjc.1998.60. Br J Cancer. 1998. PMID: 9472631 Free PMC article.

3

Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C. Gorgoulis VG, et al. Among authors: halazonetis td. Am J Pathol. 1998 Dec;153(6):1749-65. doi: 10.1016/S0002-9440(10)65690-8. Am J Pathol. 1998. PMID: 9846966 Free PMC article.

4

Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.

Zacharatos PV, Gorgoulis VG, Kotsinas A, Manolis EN, Liloglou T, Rassidakis AN, Kanavaros P, Field JD, Halazonetis T, Kittas C. Zacharatos PV, et al. Anticancer Res. 1999 Jan-Feb;19(1A):579-87. Anticancer Res. 1999. PMID: 10226602

5

Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

Satyamoorthy K, Chehab NH, Waterman MJ, Lien MC, El-Deiry WS, Herlyn M, Halazonetis TD. Satyamoorthy K, et al. Among authors: halazonetis td. Cell Growth Differ. 2000 Sep;11(9):467-74. Cell Growth Differ. 2000. PMID: 11007451

6

Chk2 leaves the PML depot.

Venere M, Mochan TA, Halazonetis TD. Venere M, et al. Among authors: halazonetis td. Nat Cell Biol. 2002 Nov;4(11):E255-6. doi: 10.1038/ncb1102-e255. Nat Cell Biol. 2002. PMID: 12415282 No abstract available.

7

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.

DiTullio RA Jr, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J, Halazonetis TD. DiTullio RA Jr, et al. Among authors: halazonetis td. Nat Cell Biol. 2002 Dec;4(12):998-1002. doi: 10.1038/ncb892. Nat Cell Biol. 2002. PMID: 12447382

8

The DNA damage checkpoint and human cancer.

Schultz LB, Chehab NH, Malikzay A, DiTullio RA Jr, Stavridi ES, Halazonetis TD. Schultz LB, et al. Among authors: halazonetis td. Cold Spring Harb Symp Quant Biol. 2000;65:489-98. doi: 10.1101/sqb.2000.65.489. Cold Spring Harb Symp Quant Biol. 2000. PMID: 12760066 Review. No abstract available.

9

The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains.

Bothos J, Summers MK, Venere M, Scolnick DM, Halazonetis TD. Bothos J, et al. Among authors: halazonetis td. Oncogene. 2003 Oct 16;22(46):7101-7. doi: 10.1038/sj.onc.1206831. Oncogene. 2003. PMID: 14562038

10

Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.

Mariatos G, Bothos J, Zacharatos P, Summers MK, Scolnick DM, Kittas C, Halazonetis TD, Gorgoulis VG. Mariatos G, et al. Among authors: halazonetis td. Cancer Res. 2003 Nov 1;63(21):7185-9. Cancer Res. 2003. PMID: 14612512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page